Using PrEP Medication to End HIV
Pre-exposure prophylaxis (PrEP), a daily regimen of two oral antiretroviral drugs in a single pill, has proven to be highly effective in preventing HIV infection for individuals at high risk, reducing the risk of acquiring HIV by up to 97 percent. (hiv.gov)
ENDING HIV
Ending the HIV Epidemic: A Plan for America will leverage the powerful data and tools now available to reduce new HIV infections in the United States by 75 percent in five years and by 90 percent by 2030.
“Today we have the right data, right tools, and right leadership to end the HIV epidemic.”
PrEP & PEP
PrEP is an HIV prevention strategy in which HIV-negative people take anti-HIV medications before coming into contact with HIV to reduce their risk of becoming infected. PrEP protects against HIV infection much like a malaria pill protects against malaria or a birth control pill protects against pregnancy. PrEP is different from post-exposure prophylaxis (PEP). PEP is taken within 72 hours after HIV exposure and involves a month-long course of anti-HIV medications. If PrEP protects against HIV infection like the birth control pill for pregnancy, think of PEP like the morning-after pill. PrEP does not protect against other sexually transmitted infections (STIs) or pregnancy and is not a cure for HIV.